Haukeland University Hospital Klinisk Forskningspost

Bergen 5021

0 studies enrolling now · 2 studies all time

What they study most

Fabry Disease

Studies at this site

• Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease — Completed
• Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function — Completed